Investor Relations

Recent Event

Proactive Investors One2One Investor Forum

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2019

Company Overview

ProPhase Labs (NASDAQ: PRPH) is a diversified medical science and technology company with deep experience with OTC consumer healthcare products and dietary supplements. The Company’s wholly owned subsidiary, ProPhase Diagnostics, Inc., is a rapidly growing CLIA laboratory business that offers COVID19 and other Respiratory Pathogen Panel (RPP) testing services.

Investor Contact Information


ProPhase Labs, Inc.
500 Office Center Drive
Suite 400
Fort Washington, PA 19034

Investor Relations

MZ Group - MZ North America
Chris Tyson
Managing Director
T: 949-491-8235